Fertility benefits company Progyny (NASDAQ:PGNY) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 10.6% year on year to $298.4 million. On top of that, next quarter’s revenue guidance ($309 million at the midpoint) was surprisingly good and 10.3% above what analysts were expecting. Its non-GAAP profit of $0.42 per share was 13.5% above analysts’ consensus estimates.
Design software company Autodesk (NASDAQ:ADSK) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 11.6% year on year to $1.64 billion. The company expects next quarter’s revenue to be around $1.61 billion, coming in 1% above analysts’ estimates. Its non-GAAP profit of $2.29 per share was 7% above analysts’ consensus estimates.
Health insurance company Alignment Healthcare (NASDAQ:ALHC) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 50.7% year on year to $701.2 million. On top of that, next quarter’s revenue guidance ($887.5 million at the midpoint) was surprisingly good and 4.1% above what analysts were expecting. Its GAAP loss of $0.16 per share was 11% above analysts’ consensus estimates.
Tesla stock has nearly given up all its gains since President Trump’s election win, as Elon Musk’s forays with politics have investors wondering where the CEO’s attention lies.
An upbeat tone is seeping into markets as investors dig into Nvidia's quarterly earnings beat, which signaled plenty of scope for growth.
Nvidia stock sank 8.5% Thursday as investor enthusiasm over Blackwell AI sales was dampened by Nvidia's lower-than-expected guidance for first quarter gross margins.
Stocks slid Thursday, weighed down by chipmaker Nvidia, which dragged semiconductor and other AI stocks lower.
Shares of medical technology company Teleflex (NYSE:TFX) fell 22.9% in the morning session after the company reported disappointing fourth-quarter results, with revenue missing expectations by a significant margin. On a constant currency basis, revenue increased 3.2%, but this still fell short of Wall Street's estimates. Weak demand in Interventional Urology wiped out gains in the Interventional and Surgical units. Looking ahead, the company's 2025 revenue guidance implies little to no growth, w
Shares of plant-based food and beverage company SunOpta (NASDAQ:STKL) fell 18.8% in the morning session after the company reported weak fourth-quarter results: its gross margin missed significantly, and its full-year EBITDA guidance fell short of Wall Street's estimates. However, SunOpta exceeded analysts' EPS projections and delivered a slight EBITDA beat. While these positive aspects are noteworthy, the overall performance for the quarter was underwhelming.
Shares of higher education company Strategic Education (NASDAQ:STRA) fell 17.6% in the afternoon session after the company reported weak fourth-quarter results, with domestic student numbers falling short of expectations. Revenue for the quarter grew modestly by 2.9% year-on-year, but operating income declined significantly compared to the same period last year. On the other hand, Strategic Education beat analysts' EPS and EBITDA expectations this quarter. Zooming out, we think this was a mixed